Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
300194.SZ Stock Price Chart
Explore Fuan Pharmaceutical (Group) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300194.SZ price movements and trends.
300194.SZ Company Profile
Discover essential business fundamentals and corporate details for Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
22 Mar 2011
Employees
3.29K
Website
https://www.fapharm.comCEO
Lu Wang
Description
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
300194.SZ Financial Timeline
Browse a chronological timeline of Fuan Pharmaceutical (Group) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 28 May 2025
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 28 May 2025.
Earnings released on 23 Apr 2025
EPS came in at -¥0.02 , while revenue for the quarter reached ¥396.19M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.06 , while revenue for the quarter reached ¥467.68M .
Earnings released on 24 Oct 2024
EPS came in at ¥0.07 , while revenue for the quarter reached ¥562.27M .
Earnings released on 30 Aug 2024
EPS came in at ¥0.08 , while revenue for the quarter reached ¥623.61M .
Dividend declared on 4 Jun 2024
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 4 Jun 2024.
Earnings released on 24 May 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥664.77M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.10 , while revenue for the quarter reached ¥809.40M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.08 , while revenue for the quarter reached ¥654.47M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥637.49M .
Dividend declared on 12 May 2023
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 12 May 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.07 , while revenue for the quarter reached ¥691.03M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥638.00M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥633.39M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.04 , while revenue for the quarter reached ¥597.66M .
Earnings released on 29 Apr 2022
EPS came in at -¥0.40 , while revenue for the quarter reached ¥626.83M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.03 , while revenue for the quarter reached ¥552.69M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.06 , while revenue for the quarter reached ¥604.89M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥572.10M .
Dividend declared on 14 May 2021
A dividend of ¥0.05 per share was announced, adjusted to ¥0.05. The dividend was paid on 14 May 2021.
Earnings released on 31 Mar 2021
EPS came in at ¥0.05 , while revenue for the quarter reached ¥649.32M .
Earnings released on 31 Dec 2020
EPS came in at ¥0.01 , while revenue for the quarter reached ¥547.74M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.05 , while revenue for the quarter reached ¥658.53M .
300194.SZ Stock Performance
Access detailed 300194.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.